EUVIMEDOntdek EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Redefining cancer photodynamic therapy with gold nanoparticles

Zoey A Lockwood iD, Michael R Jirousek, James P Basilion, Clemens Burda

Photochemistry and Photobiology · 2025-09 · 101 (5) · 1120-1138

DOI: 10.1111/php.14099 ↗

At a glance

Übersichtsarbeit in Photochemistry and Photobiology, 2025-04. Written by Zoey A Lockwood and 3 co-authors. Institution: Department of Chemistry, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio, USA. Major MEDLINE topics: Gold, Photochemotherapy, Metal Nanoparticles, Neoplasms. Cited 16 times so far (Crossref); 145 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Case Western Reserve University Expanding Horizon Initiative.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Despite advancements made in treatment options, cancer continues to be one of the leading causes of death worldwide. Photodynamic therapy (PDT) has gained attention as a minimally invasive and highly selective treatment option for cancer. However, challenges due to the hydrophobicity of photosensitizers and their poor tumor selectivity have limited their use in cancer therapy. Recent developments in nanotechnology, particularly the use of gold nanoparticles (AuNPs), help overcome these challenges. AuNPs provide a stable and biocompatible platform to deliver photosensitizers, improving their solubility, stability, and ability to target tumors while reducing side effects. Functionalized AuNPs take advantage of mechanisms like the enhanced permeability and retention (EPR) effect and active targeting, improving reactive oxygen species (ROS) production and overall therapeutic efficacy. This review explores innovations in AuNP‐based PDT systems, including ligand‐functionalized nanoparticles, bioresponsive coatings, and theranostic approaches that combine imaging with therapy. By delving into important aspects of synthesis, characterization, and functionalization, we show how AuNPs improve the delivery and performance of photosensitizers. For instance, systems functionalized with prostate‐specific membrane antigen (PSMA) have shown increased therapeutic precision and efficacy in vivo. These advancements are paving the way for more targeted and safer cancer treatments, establishing AuNP‐based PDT as a promising approach for developing highly effective oncological therapies with greater precision and fewer side effects.

Subjects

MeSH terms (MEDLINE)

GoldPhotochemotherapyMetal NanoparticlesNeoplasmsPhotosensitizing AgentsHumansAnimalsReactive Oxygen Species

Author keywords

cancer treatmentgold nanoparticlesphotodynamic therapyphotosensitizersreactive oxygen speciestargeted drug delivery

Substances

GoldPhotosensitizing AgentsReactive Oxygen Species

Authors and institutions

  • Department of Chemistry, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Radiology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

ORCID profiles: Zoey A Lockwood

Funding

  • Case Western Reserve University Expanding Horizon Initiative

Cite

APA

Lockwood, Z. A., Jirousek, M. R., Basilion, J. P., & Burda, C. (2025). Redefining cancer photodynamic therapy with gold nanoparticles. Photochemistry and Photobiology, 101(5), 1120-1138. https://doi.org/10.1111/php.14099

Vancouver

Lockwood ZA, Jirousek MR, Basilion JP, Burda C. Redefining cancer photodynamic therapy with gold nanoparticles. Photochemistry and Photobiology. 2025;101(5):1120-1138. doi:10.1111/php.14099

BibTeX
@article{Lockwood2025,
  author = {Lockwood, Zoey A and Jirousek, Michael R and Basilion, James P and Burda, Clemens},
  title = {Redefining cancer photodynamic therapy with gold nanoparticles},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  volume = {101},
  number = {5},
  pages = {1120--1138},
  doi = {10.1111/php.14099}
}
Start for free →